MIRM
#1179
Mirum Pharmaceuticals, Inc. - common stock
99.7 5 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.26%
Monthly Change
-10.97%
6 month change
+9.78%
Year Change
+42.24%
Previous Close
98.5 1
Open
99.7 5
Low
99.7 5
High
99.7 5
Volume
70
Financials
- Market Capitalization 6.48 B
- Employee 418
- Founded 2018
- CEO N/A
- Website www.mirumpharma.com
- Headquarter Delaware, United States
- FIGI BBG00MH7T2M7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-168.06
Price to sales ratio
7.61
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1118 |  SRRK Scholar Rock Holding Corporation - Common Stock | 59.26 USD | -1.30% | +6.89% | +21.88% | +97.40% | 7.22 B USD | ||
| 1138 |  ERAS Erasca, Inc. - Common Stock | 19.49 USD | +1.78% | +12.79% | +8.28% | +1125.79% | 6.82 B USD | ||
| 1185 |  COGT Cogent Biosciences, Inc. - Common Stock | 37.09 USD | +1.01% | +3.75% | -8.80% | +136.69% | 6.44 B USD | ||
| 1192 |  TVTX Travere Therapeutics, Inc. - Common Stock | 67.52 USD | +0.60% | +4.23% | +20.46% | +134.69% | 6.36 B USD |
Frequently asked questions about Mirum Pharmaceuticals, Inc. Common Stock
What is the Mirum Pharmaceuticals, Inc. Common Stock stock price today?
The current price of Mirum Pharmaceuticals, Inc. Common Stock (MIRM) is 99.75. Over the past 24 hours, the stock has changed by +1.26%. Follow the MIRM chart for real-time price dynamics.
What is the stock ticker of Mirum Pharmaceuticals, Inc. Common Stock?
Mirum Pharmaceuticals, Inc. Common Stock trades under the ticker MIRM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Mirum Pharmaceuticals, Inc. Common Stock stock going up?
MIRM has changed by +2.15% over the last week, -10.97% over the last month, and +42.24% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Mirum Pharmaceuticals, Inc. Common Stock?
Mirum Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 6.48 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Mirum Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, Mirum Pharmaceuticals, Inc. Common Stock reported earnings of -1.06 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Mirum Pharmaceuticals, Inc. Common Stock revenue for the last quarter?
Mirum Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 176.24 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Mirum Pharmaceuticals, Inc. Common Stock net income for the last quarter?
Mirum Pharmaceuticals, Inc. Common Stock reported net income of -67.23 M for the last quarter. The previous quarter showed -790.15 M, which means net income changed by +91.49%.
How many employees does Mirum Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, Mirum Pharmaceuticals, Inc. Common Stock has 418 employees. Workforce size can provide additional context about the company's scale and operations.
What is Mirum Pharmaceuticals, Inc. Common Stock EBITDA?
Mirum Pharmaceuticals, Inc. Common Stock EBITDA is -35.6 M, and its EBITDA margin is -20.2%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Mirum Pharmaceuticals, Inc. Common Stock stock?
You can buy Mirum Pharmaceuticals, Inc. Common Stock (MIRM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Mirum Pharmaceuticals, Inc. Common Stock stock?
Investing in Mirum Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MIRM chart and related analysis on metatrader.com as part of your research.